Jeremy J Bearss
Overview
Explore the profile of Jeremy J Bearss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bell T, Facemire P, Bearss J, Raymond J, Chapman J, Zeng X, et al.
PLoS Pathog
. 2024 Feb;
20(2):e1012007.
PMID: 38386661
Smallpox was the most rampant infectious disease killer of the 20th century, yet much remains unknown about the pathogenesis of the variola virus. Using archived tissue from a study conducted...
2.
Blair P, Kortepeter M, Downey L, Madar C, Downs I, Martins K, et al.
J Infect Dis
. 2020 Dec;
224(4):632-642.
PMID: 33367826
Background: Ebola virus disease (EVD) supportive care strategies are largely guided by retrospective observational research. This study investigated the effect of EVD supportive care algorithms on duration of survival in...
3.
Amemiya K, Zeng X, Bearss J, Cote C, Soffler C, Bernhards R, et al.
Trop Med Infect Dis
. 2020 May;
5(2).
PMID: 32365605
and are Gram-negative, facultative intracellular bacteria that cause melioidosis and glanders, respectively. Currently, there are no vaccines for these two diseases. Animal models have been developed to evaluate vaccines and...
4.
Amemiya K, Dankmeyer J, Bearss J, Zeng X, Stonier S, Soffler C, et al.
BMC Immunol
. 2020 Feb;
21(1):5.
PMID: 32013893
Background: Melioidosis is endemic in Southeast Asia and Northern Australia and is caused by the Gram-negative, facultative intracellular pathogen Burkholderia pseudomallei. Diagnosis of melioidosis is often difficult because of the...
5.
Cashman K, Wilkinson E, Zeng X, Cardile A, Facemire P, Bell T, et al.
mBio
. 2018 Nov;
9(5).
PMID: 30377282
Lassa virus (LASV) causes a severe, often fatal hemorrhagic disease in regions in Africa where the disease is endemic, and approximately 30% of patients develop sudden-onset sensorineural hearing loss after...
6.
Reisler R, Zeng X, Schellhase C, Bearss J, Warren T, Trefry J, et al.
Viruses
. 2018 Sep;
10(10).
PMID: 30241284
In the 2014⁻2016 West Africa Ebola Virus (EBOV) outbreak, there was a significant concern raised about the potential for secondary bacterial infection originating from the gastrointestinal tract, which led to...
7.
Coffin K, Liu J, Warren T, Blancett C, Kuehl K, Nichols D, et al.
Cell Host Microbe
. 2018 Sep;
24(3):405-416.e3.
PMID: 30173956
Sexual transmission of filoviruses was first reported in 1968 after an outbreak of Marburg virus (MARV) disease and recently caused flare-ups of Ebola virus disease in the 2013-2016 outbreak. How...
8.
Cashman K, Wilkinson E, Wollen S, Shamblin J, Zelko J, Bearss J, et al.
Hum Vaccin Immunother
. 2017 Nov;
13(12):3010-3019.
PMID: 29135337
We previously developed optimized DNA vaccines against both Lassa fever and Ebola hemorrhagic fever viruses and demonstrated that they were protective individually in guinea pig and nonhuman primate models. In...
9.
Cashman K, Wilkinson E, Shaia C, Facemire P, Bell T, Bearss J, et al.
Hum Vaccin Immunother
. 2017 Oct;
13(12):2902-2911.
PMID: 29045192
Lassa virus (LASV) is an ambisense RNA virus in the Arenaviridae family and is the etiological agent of Lassa fever, a severe hemorrhagic disease endemic to West and Central Africa....
10.
Zeng X, Blancett C, Koistinen K, Schellhase C, Bearss J, Radoshitzky S, et al.
Nat Microbiol
. 2017 Jul;
2:17113.
PMID: 28715405
Ebola virus (EBOV) persistence in asymptomatic humans and Ebola virus disease (EVD) sequelae have emerged as significant public health concerns since the 2013-2016 EVD outbreak in Western Africa. Until now,...